SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Obalon Therapeutics, Inc. of Class Action Lawsuit and Upcoming Deadline – OBLN

March 14, 2018

Responsive image

NEW YORK, March 14, 2018 /PRNewswire/ — Pomerantz LLP announces that a class action lawsuit has been filed against Obalon Therapeutics, Inc. (“Obalon” or the “Company”) (NASDAQ: OBLN) and certain of its officers. The class action, filed in United States District Court, for the Distri…

Category: Precious Metals